The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer. (Q35577964)
Jump to navigation
Jump to search
scientific article published on January 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer. |
scientific article published on January 2015 |
Statements
The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer (English)
Chiara Catania
Michela Maur
Andrea Rocca
Anna Maria Di Giacomo
Gianluca Spitaleri
Chiara Pierantoni
Reinerio González-Iglesias
Annaelisa Tasciotti
Leonardo Giovannoni
Valeria Lovato
Hans D Menssen
Filippo de Braud
1 January 2015
1 reference
1 reference